The estimated effectiveness of the respiratory syncytial virus (RSV) among older US veterans in the 2023-2024 respiratory ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

The prescribing information for Abrysvo ® (respiratory syncytial virus [RSV] vaccine) and Arexvy ® (RSV vaccine, adjuvanted) has been updated to include a new warning regarding the risk of ...

The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing information ...

Vaccinating pregnant women against RSV reduced the risk of infection in their infants by 61% compared with newborns with ...

In this note, while we briefly touch upon Pfizer’s performance in 2024, we focus on the impact on PFE stock and how 2025 ...

RSV is a contagious virus causing severe respiratory infections in infants. Vaccination during pregnancy, provides newborns ...

Expectant mothers will have access to free vaccines against respiratory syncytial virus (RSV) from next month under a major ...

The claims data suggested an increased risk of GBS during the 42 days following vaccination, with an estimated nine excess cases of GBS per million doses of Abrysvo, and an estimated seven excess ...

(WLUK) -- Wisconsin health officials confirmed the first pediatric influenza -associated death in the state for the 2024-2025 ...

A child in Wisconsin has died from the flu, the state's first pediatric flu death of the current flu season, the state Department of Health Services announced Thursday.

According to the FDA, the benefits of vaccination with Abrysvo and Arexvy continue to outweigh the potential risks. The prescribing information for Abrysvo ® (respiratory syncytial virus [RSV ...